For example, patients in Asia mainly have distal, intestinal and HER-2-positive GC, while those in western countries are mainly proximal, diffuse and HER-2-negative GC, and intestinal GC is more sensitive to postoperative chemotherapy, especially oxaliplatin-based chemotherapy (15, 16). The gene discussed is ERBB2; the disease is gastric cancer.